Study S000008

A Pilot Clinical Trial Investigating Underlying Mechanisms of Semaglutide Therapy in Heart Failure Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06541509
Acronym: SEMAHEART
Study type: INTERVENTIONAL
Phase: PHASE1; PHASE2
Masking: NONE
Status: UNKNOWN
Enrollment: 10
Start: 2024-07-10
Primary completion: 2025-07-10
Lead sponsor: University Medical Centre Ljubljana
Conditions: Heart Failure; Obesity
Interventions: DRUG:Semaglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Interleukin-6 (IL-6) [4 months]
Interleukin-8 (IL-8) [4 months]
Tumor Necrosis Factor-alpha (TNF-α) [4 months]
Interferon-gamma (IFN-γ) [4 months]
B-type Natriuretic Peptide (BNP) [4 months]
C-reactive Protein (CRP) [4 months]
Hemoglobin A1C (HgA1C) [4 months]
Complete Blood Count (CBC) [4 months]
Comprehensive Metabolic Panel (Chem 7) [4 months]
Liver Function Tests (LFT) [4 months]
Body mass index [4 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.